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1  | INTRODUCTION
Class III malocclusion makes up just 7% of malocclusions worldwide, 
and the prevalence varies widely across geographic regions and 
racial/ethnic background.1 Despite this relatively low prevalence, 
Class III disharmony is one of the most difficult and unpredictable 
malocclusions to treat in orthodontics.
Today the most common treatment protocol for correction 
of Class III malocclusion in growing patients is rapid maxillary ex-
pansion combined with facemask therapy (RME/FM).2 Despite the 
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Structured­Abstract
Objectives: To compare the three- dimensional maxillary dentoskeletal effects of a 
modified alternate rapid maxillary expansion and constriction facemask protocol (Alt- 
RAMEC/FM) with the traditional rapid maxillary expansion facemask protocol 
(RME/FM) performed in deciduous or early mixed dentition Class III patients.
Setting­and­sample­population: Orthodontic Clinic of the Section of Dentistry of the 
Department of Surgery and Translational Medicine of the University of Florence. 
Thirty- four Class III patients were enrolled and allocated by alternating assignment to 
either Alt- RAMEC/FM or RME/FM therapy.
Materials­and­Methods: Prior to treatment, all patients were evaluated, and a cone 
beam computed tomography (CBCT) scan was acquired. After completion of the or-
thopaedic therapy (average interval 1.2 years), a follow- up CBCT scan was obtained. 
Anatomic landmark identification on the CBCTs and subsequent quantification of the 
changes were performed. The primary outcome variable was the anteroposterior dis-
placement of the anterior nasal spine (ANS AP). The treatment groups were com-
pared with independent samples t tests.
Results: The patients in the two treatment groups showed a similar degree of compli-
ance. No statistically significant differences were recorded for any variable when 
comparing the Alt- RAMEC/FM and RME/FM groups. In particular, the between- 
group difference for ANS AP was 0.0 mm (95%CI: −0.6;0.7, P = 0.933).
Conclusions: Both Alt- RAMEC/FM and RME/FM produced favourable orthopaedic 
changes in Class III growing patients. Neither protocol was superior to the other in 
terms of maxillary protraction effectiveness.
K E Y WO RD S
3D imaging, class III malocclusion, dentofacial orthopedics
     |  249FISCHER Et al.
purported benefits of RME, the results of a recent systematic review 
showed that the expansion of the palate transversely does not per 
se improve maxillary protraction.3 The clinical effects of the face-
mask, which improve the Class III profile and malocclusion, can be 
attributed to the protraction of the maxilla as well as the downward 
and backward rotation of the mandible.4-6
In an effort to increase maxillary protraction and improve treat-
ment outcomes in Class III patients, Erik Liou proposed a new ortho-
paedic treatment approach that combines alternating rapid maxillary 
expansion and constriction (Alt- RAMEC) with intraoral maxillary 
protraction springs.7,8
With the promising Alt- RAMEC results reported by Liou,7,8 ad-
ditional investigators began testing this novel concept in combina-
tion with the extraoral facemask. In 2009, Do- deLatour et al9 found 
no significant difference in maxillary protraction when comparing 
the activation- deactivation/FM group and the traditional RME/FM 
group. On the other hand, in 2010 Isci et al10 reported nearly twice 
as much maxillary protraction for the Alt- RAMEC/FM protocol vs 
the RME/FM protocol. It should be noted, however, that the acti-
vation rate and duration of treatment were not consistent between 
these two studies.
Masucci et al11 in 2014 compared the RME/FM standard treat-
ment approach with a modified 4- week Alt- RAMEC/FM protocol 
performed in deciduous dentition patients to maximize protrac-
tion orthopaedic effects. The investigators reported that both the 
Alt- RAMEC/FM and RME/FM groups showed favourable maxillary 
advancement effects compared to the control group, but the Alt- 
RAMEC/FM group demonstrated a significantly greater change 
(SNA + 1.2°) in sagittal maxillary position and intermaxillary relation-
ships compared to the RME/FM group.
A randomized controlled trial (RCT) published by Liu and co- 
workers in 201512 showed that a 7- week Alt- RAMEC/FM proto-
col increased the maxillary forward movement significantly with 
respect to the RME/FM protocol (A to Vertical Axis through Sella 
+0.9 mm).
The effectiveness of the Alt- RAMEC protocol both in association 
with facemask or other protraction methods was confirmed by a re-
cent systematic review,13 although the authors emphasized the need 
for further studies to assess the stability of this treatment approach.
It should be noted, however, that only conventional 2D cephalo-
metric studies evaluating the effects of the Alt- RAMEC/FM protocol 
vs the effects of the RME/FM are available in literature. Thus, the 
objective of the current study was to compare the three- dimensional 
maxillary dentoskeletal effects of a modified alternate rapid maxillary 
expansion and constriction facemask protocol (Alt- RAMEC/FM) with 
the traditional rapid maxillary expansion facemask protocol (RME/
FM) performed in deciduous or early mixed dentition Class III patients.
2  | SUBJECTS­AND­METHODS
Ethical approval for this prospective controlled study was obtained 
from the Pediatric Ethics Committee of the Region of Tuscany, 
(#2014/0000554). Informed consent was obtained from each pa-
tient’s family prior to treatment.
A parallel quasi- randomized design with a 1:1 allocation ratio was 
implemented by alternating assignment of the Class III patients to 
either the Alt- RAMEC/FM protocol or the RME/FM protocol.
The inclusion criteria were as follows:
1.­ European ancestry (White/Caucasian).
2.­ Family history of Class III malocclusion.
3.­ Anterior crossbite or edge-to-edge incisor relationship.
4.­ Accentuated mesial step relationships of the primary second mo-
lars or Class III relationships of the permanent first molars.
5.­ Absence of CO-CR discrepancy (eg, pseudo-Class III malocclu-
sions were excluded).
6.­ Deciduous or early mixed dentition.
7.­ Prepubertal skeletal maturation CS1 to CS214,15.
8.­ Absence of craniofacial anomalies (eg, cleft lip and/or palate).
Failure to meet the inclusion criteria resulted in exclusion from 
the study. Patients who met the inclusion criteria were enrolled in 
the study following a discussion and documentation of informed 
consent with the family.
Patient recruitment was conducted in the Orthodontic Clinic 
of the Section of Dentistry of the Department of Surgery and 
Translational Medicine of the University of Florence, from September 
2011 to July 2016.
All patients received an expander and a facemask of con-
sistent designs, as have been described in a previous study.11 A 
maxillary acrylic splint expander with soldered facemask hooks 
and a 0.2 mm per turn expansion screw (Leone A2620, Leone 
Orthodontic Products, Sesto Fiorentino, Firenze, Italy) was fabri-
cated for each patient and bonded to the deciduous canines and 
deciduous molars. Parents were instructed about how to turn the 
expander.
Following the expansion phase, a petit- design facemask 
(Dynamic facemask, Leone Orthodontic Products, Sesto Fiorentino, 
Firenze, Italy) was delivered to each patient to initiate the maxillary 
protraction phase of the treatment. Elastics were attached to the 
facemask bilaterally, each delivering 400- 500 g of orthopaedic force 
in a downward and forward direction of about 30° to the occlusal 
plane.16
The Alt- RAMEC/FM protocol consisted of:
1.­ Delivery of maxillary acrylic splint expander with soldered 
facemask hooks;
2.­ Activation turns (2× per day, corresponding to 0.4 mm of expan-
sion) for maxillary expansion for 1 week;
3.­ Deactivation turns (2× per day) for maxillary constriction for 
1 week;
4.­ Repeat steps 2 and 3 so that the Alt-RAMEC cycle occurred three 
times and lasted for a total of 6 weeks;
5.­ Activation turns (2× per day) until individualized transverse di-
mension was achieved;
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6.­ Delivery of facemask and elastics and instruction of patients to 
wear the facemask for 14 hours per day for 6 months, then at 
night only for additional 6 months;
7.­ Patients were treated to achieve a positive dental overjet, with 
the goal of overcorrecting to a Class II molar relationship.
The RME/FM protocol consisted of:
1.­ Delivery of maxillary acrylic splint expander with soldered 
facemask hooks;
2.­ Activation turns (1 or 2× per day, corresponding to 0.2 or 0.4 mm 
of expansion, respectively) until individualized transverse dimen-
sion was achieved;
3.­ Delivery of facemask and elastics and instruction of patients to 
wear the facemask for 14 hours per day for 6 months, then at 
night only for an additional 6 months;
4.­ Patients were treated to achieve a positive dental overjet, with 
the goal of overcorrecting to a Class II molar relationship.
A three- dimensional CBCT image was acquired at 2 time points 
for each patient. The first CBCT was taken before treatment (T1) 
and a post- treatment CBCT (T2) was acquired 1 to 6 months after 
completion of active treatment. The CBCTs were taken exclusively 
for patients involved in this study.
The 3D analysis was performed using the open source software 
ITK- SNAP (version 2.2, www.itksnap.org) and 3D Slicer (version 
3.1, www.slicer.org). The original DICOM files were converted to 
de- identified GIPL files using ITK- SNAP. The CBCTs were acquired 
through 2 radiology centres, so the files were converted and stan-
dardized to an isotropic voxel size of 0.5 × 0.5 × 0.5 mm, using 
3DSlicer (downsize image tool in Slicer). Subsequently, 3D image anal-
ysis was performed through the following steps (Figure S1):
1.­ Construction of 3D volumetric label maps (segmentations) and 
3D surface models of the T1 scan: Using a combination of the 
3D Slicer extension Intensity Segmenter and ITK-SNAP, 3D 
segmentations of the GIPL files were constructed. The auto-
matic segmentation was generated in 3D Slicer applying a 
range file that describes the different ranges of density with 
corresponding colours to be used for the software to build 
the segmentation. The ITK-SNAP software allows the user to 
adjust the parameters of the automated features and to edit 
contours of the segmentation directly. In ITK-SNAP, the seg-
mentation also was cropped and cleaned. Then, using the 
extension model maker in 3D Slicer, the T1 segmentations 
were converted to 3D surface models (vtk files).
2.­ Head orientation in 3D Slicer: 3D Slicer provides a fixed 3D co-
ordinate system with three orthogonal planes denoted by yel-
low, red and green colours; these planes were used as a 
reference to orient the T1 models of each patient. The 
Transforms tool was used to orient the T1 model based on the 
following landmarks and planes. Glabella, Crista Galli and 
Basion were used to define the midsagittal plane and the axial 
plane was defined by the bilateral structures of Orbitale and 
Porion (Frankfort horizontal plane).
Using the axial, coronal and sagittal views of the model, the T1 
model was rotated and translated until the midsagittal plane coin-
cided with the yellow plane and the axial plane with the red plane.17 
Once oriented properly, the matrix generated from this transforma-
tion was saved and applied to the scan and segmentation for T1, 
providing the same head orientation to them. This process was re-
peated for each patient, thus achieving a common head orientation 
within the 3D Slicer coordinate system for all patients.
3.­ Manual approximation of T1 and T2: The GIPL files for T1 and 
T2 were loaded into 3D Slicer. Using the Transform tool in 
3DSlicer, the T1 oriented GIPL was selected as the stable file. 
The T2 file was moved (translated and rotated) in the left-right, 
posterior-anterior and inferior-superior planes of space to best 
approximate the superimposition of the T1 and T2 GIPL files 
on the cranial base (used as reference to achieve the 
superimposition).
4.­ Construction of 3D volumetric label maps (segmentations) of the ap-
proximated T2 scan: The same procedure described in the step #1 
was used to construct T2 segmentations. Two segmentations 
were generated for the approximated T2 scan: the full head and 
the cranial base segmentations. The cranial base segmentation 
was used in the next step to indicate to the software which re-
gions it should look for corresponding voxels in T1 and T2 to per-
form the superimposition.
5.­ Voxel-based registration of GIPL files using the cranial base as refer-
ence: The oriented T1 and the T2 approximated GIPL files with 
their corresponding segmentations were loaded into 3DSlicer. 
The 3D voxel-based registration (CMF registration tool) was used 
to align the T1 and T2 GIPL files automatically by utilizing corre-
sponding voxels in the cranial base to achieve a reliable and repro-
ducible superimposition of the 2 time points. Once this automated 
voxel-based registration was completed, the registered files (scan 
and segmentation) were used for the subsequent steps.
6.­ Placement of pre-labelled landmarks on the segmentations: The seg-
mentations were cleaned, and the mandible was removed from 
the segmentation to allow better visualization of the maxilla and 
maxillary dentition. The following eight landmarks were identi-
fied: 1 and 2) Orbitale right and left (OrR, OrL), most inferior point 
of the orbital concavity in a frontal view, centred anterior-posteri-
orly on the orbital rim from the superior view; 3 and 4) 
Infrazygomatic arch right and left (IZR, IZL), greatest point of con-
vexity where the horizontal and sagittal components of the zygo-
matic arch intersect in an inferior view; 5 and 6) Incisal tip of 
primary canine right and left (CR, CL); 7) Posterior nasal spine 
(PNS); 8) Anterior nasal spine (ANS). Attention to detail was taken 
to clean these regions throughout the segmentation process.
The segmentation of the cranial base and maxilla was performed in 
a single colour (green). The eight landmarks for T1 and T2 were 
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pre- labelled in a different colour (red) to facilitate data computation 
in future steps and minimize landmark placement error (pre- 
labelling).18 Sagittal, axial and coronal slices of the greyscale image 
as well as the 3D reconstruction of the image were used for land-
mark positioning in the ITK- SNAP software.
7.­ Generation of 3D Models (vtk files) in 3DSlicer: Using the Model 
Maker tool in 3DSlicer, 3D surface models (Figure 1) were 
generated for the segmented head and pre-labelled landmarks 
for both T1 and T2 for each patient.
8.­ Landmark based quantitative assessments in Q3DC: The Q3DC tool 
was used to calculate the millimetric changes from T1 to T2. 
Landmarks were placed on the 3D surface models, and the dis-
placement of the following landmarks was reported in anterior-
posterior and superior-inferior changes as well as 3D distances 
(midpoints were generated for bilateral landmarks): Orbitale 
Midpoint (OrM), Infrazygomatic Midpoint (IZM), Canine Midpoint 
(CM), and Anterior Nasal Spine (ANS). The changes on the palatal 
plane were measured by calculating the pitch angle between the 
palatal plane (ANS-PNS) at T1 and at T2. The anteroposterior dis-
placement of anterior nasal spine (ANS AP) was selected as pri-
mary outcome variable while all other variables were considered 
as secondary outcome variables.
Q3DC tool also was used to obtain the starting form measure-
ments for all T1 models: Vertical, Nasion (N)—Palatal Plane (ANS- 
PNS); Sagittal, ANS—Nasion Perpendicular (NPerp); Transverse, 
Intercanine Width (CC 3D); and Maxillary Length (ANS- PNS 3D).
9.­ Generation of semitransparent overlays and colormaps for visualiza-
tion: Semitransparent overlays of the T1 and T2 models were 
created for visualization. Additionally, using the Model-to-Model 
Distance and Shape Population Viewer, colormaps were gener-
ated to visualize the changes from T1 to T2.
One examiner (BHF) performed steps 1 through 5 while a second 
examiner (ACR) checked steps 1 through 5 and performed steps 6 
through 9. Both examiners were blinded to the treatment assignment.
Removable appliances in orthodontics, such as the facemask, re-
quire good compliance to achieve successful treatment outcomes. 
As anticipated, the degree of compliance varied among patients in 
this study. To monitor the patients throughout treatment, the cli-
nician recorded compliance rate at each appointment, which oc-
curred every 5 weeks. Parents were asked how often and how long 
the facemask was worn each day and it was assessed as moderate 
or excellent. Excellent compliance was noted if the patient wore the 
facemask a total of 14 hours throughout the day and night during the 
first 6 months, followed by 6 months of nighttime wear. If excellent 
compliance was not achieved, the patient’s compliance was classi-
fied as moderate.
The sample size was computed considering α = 0.05, 
power = 0.80, an effect size of 1 calculated from the standard de-
viation of 1.6° for the variable S- N- A derived from the data of the 
study by Masucci et al11 A sample size of 40 patients (20 patients 
for each group) was determined to be adequate, allowing for a 15% 
dropout rate.
Patient allocation was performed by alternating assignment to 
either one of the two treatment protocols. The two examiners who 
carried out the 3D analysis and the statistician were blinded as to 
treatment group assignment.
2.1 | Statistical­analysis
Intraclass correlation coefficient (ICC) two- way mixed with absolute 
agreement was used to test the intra- rater agreement of the exam-
iner (ACR) on 15 patients. The variables were re- measured after 
1 week. Random error was evaluated using Springate’s method of 
moments estimator (MME).19
Mean and standard deviation were used for quantitative vari-
ables, while frequency and percentage were calculated for qualita-
tive variables.
To test differences at baseline between the two groups, inde-
pendent samples t tests were used for the quantitative variables and 
Fisher’s exact tests for dichotomous variables.
To test differences between the two groups on the outcome 
variables, independent samples t tests were applied reporting P- 
values, differences between treatments and 95% confidence inter-
vals of the differences. For the primary outcome variable ANS AP 
(ie, the anteroposterior displacement of anterior nasal spine), equal-
ity of variance was assessed using Levene’s test, and an analysis 
of the residuals was performed to assess their normality using the 
Shapiro- Wilk test. If at least one of the previous tests was signifi-
cant, a sensitivity analysis was performed using the Mann- Whitney 
U test.
F IGURE  1 Surface models generated in 3DSlicer. A, Pre- labelled 
maxilla model, frontal view; B, Pre- labelled maxilla model, inferior 
view [Colour figure can be viewed at wileyonlinelibrary.com]
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For variable ANS AP, a linear model using treatment group, gen-
der, compliance and age as predictor variables also was applied.
JMP® version 13.0.0 2016 (SAS Institute Inc., Cary, NC, USA) 
and MedCalc Statistical Software version 12.7.8 (MedCalc Software 
bvba, Ostend, Belgium) were used for the statistical computations.
3  | RESULTS
Initially, 40 patients were enrolled in the study (Figure 2). The 
baseline characteristics of both groups are reported in Table 1. 
The Alt- RAMEC/FM group consisted of 20 patients (11 females, 9 
males). The average pre- treatment CBCT (T1) acquisition age was 
6.0 ± 0.9 years. The RME/FM group was comprised of 20 patients 
(12 females, 8 males). The average pre- treatment CBCT (T1) acquisi-
tion age was 6.3 ± 0.8 years. No statistically significant differences 
between the two groups were found for the 4 starting form 
measurements.
One patient of the Alt- RAMEC/FM discontinued intervention 
after 3 months of therapy due to excessive gingival inflammation. 
Five patients were excluded from analysis. Reasons for exclusion 
were the following: In the Alt- RAMEC/FM Group 2, patients’ par-
ents refused to take a second CBCT. In the RME/FM group 2, pa-
tients’ parents refused to take a second CBCT while in one patient 
the second CBCT presented with movement artefact, rendering the 
scan inadequate for landmark identification. Patient recruitment 
was conducted in the Orthodontic Clinic of the Section of Dentistry 
of the Department of Surgery and Translational Medicine of the 
University of Florence from September 2011 to July 2016.
As a result, 34 patients (18 females, 16 males) remained with 17 
patients in each treatment group. In the Alt- RAMEC/FM group, the 
average post- treatment CBCT (T2) age was 7.5 ± 1.0 years, and the 
F IGURE  2 CONSORT flow diagram [Colour figure can be viewed at wileyonlinelibrary.com]
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average T1- T2 interval was 1.6 ± 0.2 years. Treatment duration in 
this group was 1.2 ± 0.1 years. In the RME/FM group, the average 
post- treatment CBCT (T2) age was 8.0 ± 0.8 years, and the average 
T1- T2 interval was 1.5 ± 0.3 years. Treatment duration in this group 
was 1.1 ± 0.2 years.
The patients of the two treatment groups showed a similar de-
gree of compliance. In the Alt- RAMEC/FM group, 9 patients (47%) 
showed excellent compliance, and 10 patients (53%) exhibited mod-
erate compliance. In the RME/FM group, 9 patients (45%) showed ex-
cellent compliance, 11 patients (55%) exhibited moderate compliance. 
No statistically significant differences were found between the two 
groups in terms of degree of compliance (P = 1.0).
The ICCs are reported in Table 2. The values varied from 0.84 to 
0.98, indicating excellent intra- rater agreement.20 The MME random 
error measurements ranged from 0.12 to 0.32 mm. Inter- observer 
agreement, using similar methods and involving the same examiner 
(ACR), had been tested already in a previous study17 that revealed 
excellent agreement.
Statistical comparisons for the T1- T2 changes of the Alt- RAMEC/
FM and RME/FM groups are reported in Table 3. There were no sta-
tistically significant differences between the two treatment groups. 
Levene’s test and the Shapiro- Wilk test were not significant for the 
primary outcome variable ANS AP.
The amount of anterior- posterior and superior- inferior displace-
ment of the maxilla was proportional at about 1:1 ratio in both 
groups. The maxilla, as measured at ANS, was protracted by 2.0 mm 
in both groups and was displaced inferiorly by 2.4 mm in the Alt- 
RAMEC/FM group and 2.1 mm in the RME/FM group. Less skeletal 
displacement was observed at the infrazygomatic midpoint, with the 
Alt- RAMEC/FM group showing 1.0 mm anterior and 2.0 mm inferior 
displacement, and the RME/FM group showing 1.2 mm anterior and 
1.7 mm inferior displacement. The greatest changes were found at 
the primary canines with a forward displacement of 3.4 mm and an 
inferior displacement of 4.2 mm in the Alt- RAMEC/FM group and 
a forward displacement of 3.5 mm and an inferior displacement of 
3.9 mm in the RME/FM group. As illustrated in Figure 3, patients 
in both groups varied in the amount and direction of dentoskeletal 
change as a response to treatment.
As for the results of the linear regression analysis, no significant 
predictor was identified for the primary outcome variable ANS AP. 
Adjusted difference for ANS AP between the 2 treatments was 
0.00 mm (95%CI: −0.73; 0.73).
4  | DISCUSSION
The present study evaluated the three- dimensional maxillary den-
toskeletal effects of a 6- week Alt- RAMEC/FM protocol with respect 
to the conventional RME/FM protocol in Class III growing patients. 
To our knowledge, no previous study analyzed the three- dimensional 
maxillary changes produced by the Alt- RAMEC/FM protocol vs the 
RME/FM protocol.
In this study, we choose to treat Class III patients during the early 
developmental stage, according to the study by Masucci et al11, for 
two reasons. First, the forces generated during the repetitive weekly 
expansion/constriction protocol could produce negative periodontal 
effects and increase the risk of root resorption on maxillary first pre-
molars and permanent molars13. These side effects could be avoided 
if the expansion/constriction forces were applied on the deciduous 
teeth. Secondly, the deciduous dentition phase coincides with a 
stage of skeletal development that is considered to be optimal for 
the correction of dentoskeletal Class III malocclusion as a good re-
sponse to maxillary protraction is achieved during the prepubertal 
stage of skeletal maturation.14
TABLE  1 Statistical comparisons for gender, age for CBCT at T1, 
and 4 variables at baseline (T1)
Variable
Alt-­RAMEC/FM­
N­=­20
RME/FM­
N­=­20 P-­value
Gender 
(Female)
11 (55%) 12 (60%) 1.000
Age CBCT at 
T1 (y)
6.0 (0.9) 6.3 (0.8) 0.250
N PalPI SI (mm) 41.4 (2.2) 41.8 (2.3) 0.522
ANS- NPerp AP 
(mm)
0.4 (2.6) 1.0 (2.3) 0.386
CC 3D (mm) 28.3 (1.7) 28.1 (2.7) 0.744
ANS- PNS 3D 
(mm)
42.4 (2.0) 42.8 (2.8) 0.647
AP, antero- posterior; CBCT, cone beam computed tomography; CC, in-
tercanine width; NPerp, nasion perpendicular; PalPl, palatal plane; SI, 
supero- inferior.
TABLE  2 Mean differences between the two measures, 
intraclass correlation coefficient (ICC) with 95% confidence interval 
(CI) and random error evaluated using the method of moments 
estimator (MME)
Variable Mean­diff. ICC 95%CI
MME­(mm­
or­degrees)
OrM AP (mm) 0.15 0.87 0.65; 0.95 0.25
OrM SI (mm) 0.19 0.84 0.58; 0.94 0.32
OrM 3D (mm) −0.02 0.84 0.57; 0.94 0.29
IZM AP (mm) 0.10 0.89 0.70; 0.96 0.25
IZM SI (mm) 0.10 0.87 0.67; 0.96 0.28
IZM 3D (mm) −0.06 0.88 0.67; 0.96 0.27
CM AP (mm) 0.22 0.98 0.67; 0.99 0.13
CM SI (mm) 0.14 0.98 0.93; 0.99 0.28
CM 3D (mm) 0.03 0.98 0.95; 0.99 0.20
ANS AP (mm) 0.06 0.98 0.94; 0.99 0.12
ANS SI (mm) 0.10 0.95 0.87; 0.98 0.22
ANS 3D (mm) −0.04 0.97 0.91; 0.99 0.20
ANS- PNS 
Angle (°)
0.09 0.98 0.95; 0.99 0.19
AP, antero- posterior; diff., difference; SI, supero- inferior.
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Using a newly developed extension in 3D Slicer,21 the Q3DC tool 
was used for landmark identifications in T1 and T2 for each patient. 
The Q3DC extension then calculated the three- dimensional change 
at each landmark and decomposed the measurement into compo-
nent parts, providing the magnitude (millimetric) and direction of 
change. In contrast to the quantitative assessments using Q3DC, 
the semitransparent overlays in Figure 3 provided a qualitative vi-
sual representation of treatment results, respectively for the Alt- 
RAMEC/FM and RME/FM groups.
The individual variability of patients’ response to therapy also is 
noteworthy, indicating other possible underlying factors related to 
treatment response rather than to the therapy of choice. While both 
treatment protocols led to marked maxillary protraction in some pa-
tients, the vertical growth component in other patients treated with 
the same protocol was obvious.
When comparing descriptive statistics across the two groups in 
the present study, the Alt- RAMEC/FM group and RME/FM group 
had similar demographics and starting form. When evaluating treat-
ment outcomes, no significant difference was detected between the 
Alt- RAMEC/FM and RME/FM groups. Measured at ANS, the 3D 
displacement of the maxilla with growth and response to treatment 
was on average 3.4 mm in the Alt- RAMEC/FM group and 3.2 mm 
in the RME/FM group. In both groups, the maxillary changes mea-
sured at ANS occurred on average 2.0 mm in the anterior direction 
(2.0 ± 1.0 mm in the Alt- RAMEC/FM group and 2.0 ± 0.9 mm in the 
RME/FM group). A similar amount of maxillary displacement of ANS 
occurred in a downward direction (−2.4 ± 1.0 mm in the Alt- RAMEC/
FM group and −2.1 ± 1.2 mm in the RME/FM group).
This finding is not consistent with the results reported by Do- 
deLatour et al,9 who found no significant differences in maxillary 
advancement between the Alt- RAMEC/FM group (1.8 mm) and the 
RME/FM group (2.6 mm) in two 8.5- year- old samples of Class III pa-
tients. It is interesting to note that Do- deLatour et al9 applied a more 
aggressive Alt- RAMEC protocol (1 mm/d for 7 weeks, similar to the 
original protocol proposed by Liou7) than that used in the current 
study (0.4 mm/d for 6 weeks).
Also, authors found more favourable treatment outcomes in 
patients undergoing alternating expansion/constriction protocols 
with respect to the conventional RME/FM protocol.10-12 In particu-
lar, Isci et al10 evaluated the effects of an Alt- RAMEC/FM treatment 
in 11- year- old Class III patients by applying an Alt- RAMEC protocol 
that was similar to the one used in the current study (0.4 mm/d for 
4 weeks). The authors reported more favourable maxillary advance-
ment in the Alt- RAMEC/FM group (4.1 mm) compared to the RME/
FM group (2.3 mm). Similar results were published by Liu et al,12 
who found an increased maxillary forward movement with the Alt- 
RAMEC/FM protocol (1 mm/d for 7 weeks) with respect to the con-
ventional RME/FM protocol (A to Vertical Axis through Sella 3.0 and 
2.1 mm, respectively) both performed in 10- year- old Class III patients.
The age of the patients at the start of treatment also could 
be a factor contributing to the difference in clinical outcomes be-
tween the present study and the studies by Isci et al10 and Liu et al12 
Masucci et al,11 who evaluated the treatment outcomes of the Alt- 
RAMEC (0.4 mm/d for 6 weeks) vs RME protocols combined with 
FM in 6- year- old Class III patients, also reported data that is not con-
sistent with the results of the present study. The investigators found 
that the Alt- RAMEC/FM group showed a significantly greater max-
illary advancement (SNA 2.7°) with respect to the RME/FM group 
(SNA 1.5°).
When explaining these dissimilarities in terms of maxillary pro-
traction, it should be stressed that there are at least 2 main differ-
ences in terms of methodology between the present study and the 
previous studies10-12 that analyzed the effects of the Alt- RAMEC/
FM protocol vs the RME/FM protocol. Firstly, the present study per-
formed a three- dimensional evaluation of the effects of treatment. 
The T1- T2 changes were assessed after superimposition of the scan 
Variable
Alt-­RAMEC/FM­
N­=­17
RME/FM­
N­=­17 Differences 95%CI P-­value
OrM AP (mm) 0.8 (0.8) 1.3 (0.9) −0.5 −1.1; 0.1 0.095
OrM SI (mm) −1.0 (0.6) −0.6 (0.6) −0.3 −0.8; 0.1 0.127
OrM 3D (mm) 1.6 (0.5) 1.7 (0.7) −0.1 −0.5; 0.3 0.634
IZM AP (mm) 1.0 (0.7) 1.2 (0.8) −0.2 −0.7; 0.3 0.522
IZM SI (mm) −2.0 (0.9) −1.7 (0.8) −0.3 −0.9; 0.3 0.293
IZM 3D (mm) 2.5 (0.6) 2.2 (0.7) 0.3 −0.2; 0.7 0.299
CM AP (mm) 3.4 (1.2) 3.5 (1.2) −0.1 −1.0; 0.7 0.794
CM SI (mm) −4.2 (1.3) −3.9 (1.8) −0.3 −1.3; 0.9 0.642
CM 3D (mm) 5.6 (0.9) 5.5 (1.6) 0.1 −0.8; 1.0 0.781
ANS AP (mm) 2.0 (1.0) 2.0 (0.9) 0.0 −0.7; 0.6 0.933
ANS SI (mm) −2.4 (1.0) −2.1 (1.2) - 0.3 −1.1; 0.4 0.403
ANS 3D (mm) 3.4 (0.7) 3.2 (1.0) 0.2 −0.3; 0.8 0.421
ANS- PNS 
Angle (°)
−0.2 (1.5) 0.2 (1.5) −0.5 −1.5; 0.6 0.358
AP, antero- posterior; SI, supero- inferior.
TABLE  3 Statistical comparisons for 
the T1- T2 changes
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at T1 and the scan at T2 on the stable structures of the cranial base. 
This procedure allowed for more reliable and precise analysis results 
with respect to the previous 2D studies.10-12 Secondly, all these 
studies used point A to evaluate maxillary advancement. It should be 
emphasized, however, that the reliability of the localization of point 
A can be influenced by the position of the upper central incisors, es-
pecially during the eruption period (Figure 4). For these reasons, the 
present study adopted the ANS point to assess maxillary movement.
If the amount of maxillary advancement reached with both 
protocols (2.0 mm) is considered, it is consistent with the data 
reported by several authors4,5,16 in the literature on the effects 
of RME/FM treatment (1.5- 3 mm) and it confirms the efficacy of 
FM protraction therapy produced by both Alt- RAMEC and RME 
protocols.
Although not as great in magnitude as the maxillary change, 
the zygomatic movement, as measured from the infrazygomatic 
landmarks, followed the same downward and forward trend 
(Figure 3). This study measured changes at the infrazygomatic 
midpoint to evaluate the zygomatic changes and to eliminate the 
expansion variable when determining the 3D distances from T1 to 
T2. The 3D displacement of infrazygomatic midpoint was on aver-
age 2.5 ± 0.6 mm in the Alt- RAMEC/FM group and 2.2 ± 0.7 mm 
in the RME/FM group. Different from the maxilla, the growth 
and treatment changes at the zygoma occurred more in an infe-
rior direction (−2.0 ± 0.9 and −1.7 ± 0.8 mm, respectively in the 
Alt- RAMEC/FM and RME/FM groups) than in anterior direction 
(1.0 ± 0.7 and 1.2 ± 0.8 mm, respectively in the Alt- RAMEC/FM 
and RME/FM groups).
The primary canines, as measured by the generated midpoint, 
moved in the Alt- RAMEC/FM group and in the RME/FM group 
5.6 mm (3D) and 5.5 mm (3D) respectively and 3.4 mm (AP) and 
3.5 mm (AP) of that movement was in the anterior direction. These 
data provide insight into the amount of anchorage loss that occurred 
despite the use of the bonded expander in the primary dentition. 
Knowing that the maxilla came forward 2.0 mm in both groups and 
the canines came forward 3.5 mm, it can be postulated that there 
was 1.5 mm of forward dental movement, or anchorage loss, during 
protraction therapy. This mesial movement of the dentition can 
improve the Class III dental relationship, but it may contribute to 
anterior crowding or upper incisor flaring that is reported in the lit-
erature3 as a common side effect of facemask therapy. It should be 
noted that the permanent maxillary first molar, if present, was not 
used for anchorage.
Another factor that may have led to no significant differences 
in treatment outcomes between the groups could be related to the 
timing of treatment. The Alt- RAMEC protocol7 originally was pro-
posed to disarticulate the maxilla and produce more effective mid-
facial protraction. In the current study, however, both Alt- RAMEC 
and RME protocols were performed at an early age when the cir-
cummaxillary sutures are not interdigitated.22 In fact, the greatest 
amount of maxillary protraction has been reported in studies10,12 
that started Alt- RAMEC treatment closer to puberty when the cir-
cummaxillary sutures have become heavily interdigitated.22 At that 
stage, the Alt- RAMEC protocol may be more effective in loosening 
the maxillary sutures than conventional RME.
The results of this study suggest that both Alt- RAMEC/FM and 
RME/FM protracted the maxilla in a forward and downward di-
rection effectively; however, limitations of the current study were 
the absence of randomization and the lack of an untreated control 
group or FM- only group without expansion. Moreover, long- term 
follow- up of these patients would provide clinicians with valuable 
information to evaluate if the there is a difference in the amount of 
maxillary protraction that is retained following active growth.
F IGURE  3  Individual variability in patient response to therapy 
with Alt- RAMEC, as shown by semitransparent overlays of 3D 
surface models superimposed in the cranial base. A, patient 
who presented predominantly vertical changes at the orbit and 
zygoma, as shown in close- up view of the floor of the orbit. The 
maxillary growth also was predominantly vertical. B, patient who 
presented favourable maxillary anterior protraction with some 
vertical displacement with growth. C, patient who presented 
predominantly vertical changes at the orbit and zygoma, as shown 
in close- up view of the floor of the orbit. The maxillary growth also 
was predominantly vertical. D, patient who presented favourable 
maxillary anterior protraction [Colour figure can be viewed at 
wileyonlinelibrary.com]
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5  | CONCLUSIONS
• The Alt-RAMEC/FM and RME/FM protocols are effective treat-
ment protocols for correction of Class III malocclusion in patients 
in the deciduous/early mixed dentition.
• The Alt-RAMEC/FM and RME/FM protocols produced similar 
skeletal and dental effects, with neither group providing a more 
favourable outcome.
• Skeletal effects of the protraction, as measured at ANS and in-
frazygomatic midpoint, resulted in ~50% forward (A-P) and ~50% 
downward (S-I) movement.
• Despite the use of a bonded expander, both groups exhibited 
more forward and downward dental movement, as measured at 
the primary canine, when compared to the movement measured 
at the skeletal landmarks.
ORCID
L. Franchi  http://orcid.org/0000-0002-2072-460X 
REFERENCES
 1. Hardy DK, Cubas YP, Orellana MF. Prevalence of angle class III mal-
occlusion: a systematic review and meta- analysis. Open J Epidemiol. 
2012;2:75-82.
 2. McNamara JA Jr, Brudon WL. Orthodontics and Dentofacial 
Orthopedics. Ann Arbor, Michigan: Needham Press; 2001:375-385.
 3. Foersch M, Jacobs C, Wriedt S, Hechtner M, Wehrbein H. 
Effectiveness of maxillary protraction using facemask with or with-
out maxillary expansion: a systematic review and meta- analysis. 
Clin Oral Investig. 2015;19:1181-1192.
 4. Cordasco G, Matarese G, Rustico L, et al. Efficacy of orthopedic 
treatment with protraction facemask on skeletal Class III malocclu-
sion: a systematic review and meta- analysis. Orthod Craniofac Res. 
2014;17:133-143.
 5. Woon SC, Thiruvenkatachari B. Early orthodontic treatment for 
Class III malocclusion: a systematic review and meta- analysis. Am J 
Orthod Dentofacial Orthop. 2017;151:28-52.
 6. Rongo R, D’Antò V, Bucci R, Polito I, Martina R, Michelotti A. 
Skeletal and dental effects of Class III orthopaedic treatment: a sys-
tematic review and meta- analysis. J Oral Rehabil. 2017;44:545-562.
 7. Liou EJ-W. Effective maxillary orthopedic protraction for growing 
Class III patients: a clinical application simulates distraction osteo-
genesis. Prog Orthod. 2005;6:154-171.
 8. Liou EJ-W. Toothborne orthopedic maxillary protraction in Class III 
patients. J Clin Orthod. 2005;39:68-75.
 9. Do-deLatour TB, Ngan P, Martin CA, Razmus T, Gunel E. Effect of 
alternate maxillary expansion and contraction on protraction of the 
maxilla: a pilot study. Hong Kong Dent J. 2009;6:72-82.
 10. Isci D, Turk T, Elekdag-Turk S. Activation- deactivation rapid pala-
tal expansion and reverse headgear in Class III cases. Eur J Orthod. 
2010;32:706-715.
 11. Masucci C, Franchi L, Giuntini V, Defraia E. Short- term effects of a 
modified Alt- RAMEC protocol for early treatment of Class III maloc-
clusion: a controlled study. Orthod Craniofac Res. 2014;17:259-269.
 12. Liu W, Zhou Y, Wang X, Liu D, Zhou S. Effect of maxillary protrac-
tion with alternating rapid palatal expansion and constriction vs 
expansion alone in maxillary retrusive patients: a single- center, 
randomized controlled trial. Am J Orthod Dentofacial Orthop. 
2015;148:641-651.
 13. Pithon MM, Santos NL, Santos CR, et al. Is alternate rapid maxillary 
expansion and constriction an effective protocol in the treatment 
of Class III malocclusion? A systematic review. Dental Press J Orthod. 
2016;21:34-42.
 14. Baccetti T, Franchi L, McNamara JA Jr. The cervical verte-
bral maturation (CVM) method for the assessment of optimal 
treatment timing in dentofacial orthopedics. Semin Orthod. 
2005;11:119-129.
 15. McNamara JA Jr, Franchi L. The cervical vertebral maturation 
method: a user’s guide. Angle Orthod. 2018;88:133-143.
 16. Ngan P, Hagg U, Yiu C, Wei SH. Treatment response and long- term 
dentofacial adaptations to maxillary expansion and protraction. 
Semin Orthod. 1997;3:255-264.
 17. Ruellas AC, Tonello C, Gomes LR, et al. Common 3- dimensional co-
ordinate system for assessment of direction changes. Am J Orthod 
Dentofacial Orthop. 2016;149:645-656.
 18. Ruellas AC, Huanca Ghislanzoni LT, Gomes MR, et al. Comparison 
and reproducibility of 2 regions of reference for maxillary regional 
F IGURE  4  Images of before (T1) and after therapy (T2) scans displaying upper incisors eruption during the interval between both scans. 
The vertical displacement of the upper permanent central incisor inside the alveolar bone may influence changes in Point A. When the 
crown of the incisor was at the level of the point A, Point A appeared more prominent anteriorly than when the central incisor had erupted 
previously (and the root was at the level of Point A)
     |  257FISCHER Et al.
registration with cone- bean computed tomography. Am J Orthod 
Dentofacial Orthop. 2016;149:533-542.
 19. Springate SD. The effect of sample size and bias on the reliability of 
estimates of error: a comparative study of Dahlberg’s formula. Eur J 
Orthod. 2012;34:158-163.
 20. Fleiss JL. The design and analysis of clinical experiments. New York, 
NY: John Wiley and Sons, Inc.; 1986:7.
 21. Fedorov A, Beichel R, Kalpathy-Cramer J, et al. 3D slicer as an image 
computing platform for the quantitative imaging network. Magn 
Reson Imaging. 2012;30:1323-1341.
 22. Melsen B, Melsen F. The postnatal development of the palato-
maxillary region studied on human autopsy material. Am J Orthod. 
1982;82:329-342.
SUPPORTING­INFORMATION
Additional supporting information may be found online in the 
Supporting Information section at the end of the article. 
How­to­cite­this­article: Fischer B, Masucci C, Ruellas A, et al. 
Three- dimensional evaluation of the maxillary effects of two 
orthopaedic protocols for the treatment of Class III 
malocclusion: A prospective study. Orthod Craniofac Res. 
2018;21:248–257. https://doi.org/10.1111/ocr.12247
